A method for the treatment of streptococcus pneumoniae infection
CA 2264794 A1 · Owner: Ambi Inc. · Inventors: Goldstein, Beth P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns methods for killing antibiotic-resistant pathogenic bacteria which cause disease in humans and animals. In particular the methods , are directed to the killing of antibiotic-resistant or multi-drug resistant Streptococcus pneumoniae bacterial strains. The methods employ a lanthocin such as nisin or a variant thereof as bactericidal agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 14, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 14, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 14, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.